Archives

Autosomal Dominant Polycystic Kidney Disease: An Overview Of Pathology, Diagnosis & Disease Progression
This event has been canceled until further notice.
Join autosomal dominant polycystic kidney disease (ADPKD) experts, where you can hear the most current information on ADPKD pathophysiology, disease progression, and the physical and emotional burden of ADPKD.
Objectives
- Review of the recent advancements made in the ADPKD field
- Address key factors that play into ADPKD
- Highlight and evaluate prognostic indicators of advanced ADPKD outcomes
*Drs Sachin Hajarnis and Cibele Pinto are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
In Collaboration With

Featured Speakers

Sachin Hajarnis, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Sachin Hajarnis, PhD is a Senior Medical Science Liaison at Otsuka Pharmaceuticals. Dr Hajarnis has a Bachelors and Masters in Life Sciences from University of Mumbai, India. He obtained a PhD in Biochemistry and Molecular Biology from Colorado State University. Dr Hajarnis joined the University of Texas Southwestern Medical school in Dallas, as a post-doctoral fellow in the department of Nephrology where he performed basic research on various aspects of Polycystic Kidney Disease (PKD). He continued his studies on the role of micro-RNAs in PKD as a Research Scientist for several years before joining his current position at Otsuka.
Location
Online